©News Group Newspapers Limited in England No. 679215 Registered office: 1 London Bridge Street, London, SE1 9GF. "The Sun", ...

Vermont has the second lowest state fatality rate in the US (147.9 per 100K; Hawaii 113.5/100K). Mississippi (465.6/100K) and ...

Kylian Mbappe of Real Madrid has been hospitalized with acute gastroenteritis, a significant blow to both the team and the inaugural tournament. The i ...

Blujepa: Most recently, the U.S. Food and Drug Administration (FDA) approved Blujepa (gepotidacin), the first of a new class of drugs for the treatment of uncomplicated urinary tract infections caused ...

AI Impact Winner: Every Cure Newsweek Illustration Every Cure was founded by Dr. David Fajgenbaum and Dr. Grant Mitchell in 2010, in response to a personal crisis. As a third-year medical student ...

We aren't quite clear of peak norovirus season just yet, and if you come down with the debilitating virus, the symptoms could linger in your system for some time. Here's what you need to know if ...

Vaxart (NASDAQ:VXRT) stock jumped 37.9% premarket after the company reported positive early-stage data for its second-generation oral norovirus vaccine pill, with antibody responses up 141% ...

Vaxart, Inc., a biotechnology company focused on oral recombinant pill vaccines, announced it will release topline data from its Phase I trial on norovirus before the market opens on June 11, 2025.

The intention is to make it much easier for people to get ivermectin and use it for any ailment they believe it can cure. Idaho, Arkansas, and Tennessee have passed laws to make ivermectin ...

A new era of hypertension treatment is on the horizon for U.S. | The drug is the first triple-combo pill for the initial treatment of hypertension in the U.S.